Melanoma on Congenital Nevi: Case Report
Journal: International Journal of Clinical Dermatology & Research (IJCDR) (Vol.06, No. 05)Publication Date: 2018-08-17
Authors : Niema Aqil Ghita Senhaji Sara Elloudi Hanane Baybay Fatima Zahra Mernissi;
Page : 180-183
Keywords : CMN: Congenital Melanocytic Nevus; PN: Proliferative Nodule.;
Abstract
Introduction: Congenital nevi occur in about 1% of newborns. The most used classification is based on their size; small congenital naevus when the largest diameter is less than 1.5cm, intermediate naevi for those between 1.5 and 19.9cm, wide naevus when the diameter is greater than 20cm, and giant naevus when the size is greater than 40cm, with frequent satellite lesions. The risk of transformation into melanoma is estimated at 6.3% for giant nevi, it usually occurs before the age of 20, hence the indication of early excision. This risk is even lower as the size of the nevus is small, and the transformation is usually late. We report the case of a patient with melanoma occurring on a congenital melanocytic naevi of intermediate size. Case Presentation: We report the case of a 54-year-old patient, with no pathological antecedents, who was born with a congenital nevus of the right shoulder with onset 7 months ago of a nodule within the old lesion, increasing rapidly of which the histological study had concluded to a melanoma. Discussion: Melanoma can also occur in congenital nevi less than 10cm in size. They can be considered as precursors of melanoma. Because of their large number and frequency, prophylactic excision of all these nevi is not feasible. However, they should be removed as soon as possible when clinical or dermoscopic changes are observed.
Other Latest Articles
- Plasma Lipid Profile Parameters and Their Internal Ratios in Clinically Sub - Grouped Psoriasis Patients
- Effect of Plant Extracts on Innate Immunity of Skin Cells: Investigations on Human Keratinocyte Cell Lines
- Effect of Plant Extracts on Innate Immunity of Skin Cells: Investigations on Human Keratinocyte Cell Lines
- A Randomized, Blinded, Placebo-Controlled Study Of BVP-01, A Proprietary Nutraceutical Formulation For The Treatment Of Canine Osteoarthritis
- Review On Antibiotics Residue In Beef: Its Risk Factors and Public Health Impacts
Last modified: 2021-12-09 18:39:35